SPY357.46+2.13 0.60%
DIA295.89+3.36 1.15%
IXIC11,880.63+25.66 0.22%

Akero Therapeutics Q3 EPS $(0.63) Down From $(0.56) YoY

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.63) per share. This is a 12.5 percent decrease over losses of $(0.56) per share from the same period last year.

· 11/12/2020 16:13
Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.63) per share. This is a 12.5 percent decrease over losses of $(0.56) per share from the same period last year.